X-linked Adrenoleukodystrophy
📧 Sign up to get email alerts when something new happens for X-linked Adrenoleukodystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-12-16Clinical Trial Update: Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) [Phase 2]
A Phase 2 clinical trial evaluating PXL770 for Adrenomyeloneuropathy (AMN), a form of X-linked adrenoleukodystrophy, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-02-14Clinical Trial Update: Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD) [Phase 1]
Phase 1 safety and pharmacodynamic study of sobetirome in X-linked adrenoleukodystrophy has been withdrawn.